Trials / Recruiting
RecruitingNCT06592755
Single-Incision Gasless Endoscopic Total Thyroidectomy Via Subclavian Approach Versus Open Surgery for PTC
Single-Incision Gasless Endoscopic Total Thyroidectomy Via Subclavian Approach Versus Open Surgery for Papillary Thyroid Carcinoma
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Historically, performing a contralateral thyroid lobectomy and lymph node dissection via the subclavian approach was considered challenging. This study aimed to evaluate the safety and feasibility of single-incision gasless endoscopic total thyroidectomy and central compartment neck dissection via the subclavian approach (SCA) in comparison to conventional open surgery for the treatment of papillary thyroid carcinoma (PTC) retrospectively.
Detailed description
Historically, performing a contralateral thyroid lobectomy and lymph node dissection via the subclavian approach was considered challenging. This study aimed to evaluate the safety and feasibility of single-incision gasless endoscopic total thyroidectomy and central compartment neck dissection via the subclavian approach (SCA) in comparison to conventional open surgery for the treatment of papillary thyroid carcinoma (PTC) retrospectively.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | single-incision, gasless endoscopic total thyroidectomy with central compartment neck dissection | The included patients chose to undergo single-incision, gasless endoscopic total thyroidectomy with central compartment neck dissection via the subclavian approach based on patients preference. |
| PROCEDURE | conventional open surgery | These patients chose to undergo total thyroidectomy with central compartment neck dissection via conventional open surgery based on patients preference. |
Timeline
- Start date
- 2024-09-20
- Primary completion
- 2024-09-30
- Completion
- 2024-09-30
- First posted
- 2024-09-19
- Last updated
- 2024-10-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06592755. Inclusion in this directory is not an endorsement.